1. Management of chronic myeloid leukaemia in relapse following donor lymphocyte infusion induced remission: a retrospective study of the Clinical Trials Committee of the British Society of Blood & Marrow Transplantation (BSBMT). Cummins M, Cwynarski K, Marktel S, Dazzi F, Cavenagh J, Clark RE, Holyoake TL, Milligan D, Parker A, Russell NH, Marks DI; Clinical Trials Committee British Society of Blood & Marrow Transplantation (BSBMT). Bone Marrow Transplant. 2005 Dec;36(12):1065-9.
2. Analysis of outcome following allogeneic haemopoietic stem cell transplantation for myeloma using myeloablative conditioning–evidence for a superior outcome using melphalan combined with total body irradiation.Hunter HM, Peggs K, Powles R, Rahemtulla A, Mahendra P, Cavenagh J, Littlewood T, Potter M, Hunter A, Pagliuca A, Williams CD, Cook G, Towlson K, Marks David I, Russell NH; Clinical Trials Committee of the British Society of Blood and Marrow Transplantation (BSBMT). Br J Haematol. 2005 Feb;128(4):496-502.
3.Less than half of patients aged 65 years or under with myeloma proceed to transplantation: results of a two region population-based survey.
Morris TC, Velangi M, Jackson G, Marks DI, Ranaghan L; Northern Ireland Regional Haematology Group; Northern Regional Haematologists Group; Clinical Trials Committee of The British Scoiety for Blood and Marrow Transplantation. Br J Haematol. 2005 Feb;128(4):510-2.